30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Abcellera Biologics Inc (ABCL)

Track

Over the last 90 days, insider trading at Abcellera Biologics Inc. shows a net buy of $95,400 from one insider. This follows a period of consistent buying activity from multiple insiders and entities, including significant purchases by Thermopylae Holdings Ltd. and John S. Montalbano. The stock has seen a 47.2% increase in the last 90 days.
Stock chart
Ticker: ABCL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Montalbano John S.
1 purchase — total 95,400 USD
Buy 14 May 2026
Value US$3,134,207.86 | Price 157.91 | Shares 48,860
Buy 27 Feb 2026
Value US$2,890,389.27 | Price 26.42 | Shares 3,444
Buy 27 Feb 2026
Value US$145,692.00 | Price 3.42 | Shares 42,600
Buy 26 Feb 2026
Value US$580,284.39 | Price 3.27 | Shares 177,457
Buy 26 Nov 2025
Value US$178,460.00 | Price 3.57 | Shares 50,000
Buy 11 Mar 2025
Value US$742,242.96 | Price 2.16 | Shares 343,631
Buy 10 Mar 2025
Value US$57,500.00 | Price 2.30 | Shares 25,000
Buy 6 Mar 2025
Value US$140,568.00 | Price 2.34 | Shares 60,000
Buy 29 Aug 2024
Value US$739,976.76 | Price 2.61 | Shares 283,516
Buy 8 Nov 2023
Value US$44,600.00 | Price 4.46 | Shares 10,000
Buy 6 Nov 2023
Value US$92,800.00 | Price 4.64 | Shares 20,000
Buy 22 Sep 2023
Value US$98,200.00 | Price 4.91 | Shares 20,000
Buy 12 Sep 2023
Value US$103,800.00 | Price 5.19 | Shares 20,000
Buy 8 Aug 2023
Value US$177,000.00 | Price 5.90 | Shares 30,000
Buy 26 May 2023
Value US$99,325.00 | Price 6.85 | Shares 14,500
Buy 26 May 2023
Value US$997,728.30 | Price 6.52 | Shares 153,000
Buy 16 Dec 2022
Value US$859,249.36 | Price 10.10 | Shares 85,102
Buy 19 Aug 2022
Value US$2,292,460.00 | Price 11.46 | Shares 200,000
Buy 14 Jun 2022
Value US$73,841.73 | Price 8.05 | Shares 9,173
Buy 13 Jun 2022
Value US$441,066.30 | Price 8.03 | Shares 54,915
Buy 6 Jun 2022
Value US$483,964.86 | Price 7.50 | Shares 64,545
Buy 16 May 2022
Value US$1,267,780.00 | Price 6.34 | Shares 200,000
Buy 13 May 2022
Value US$2,176,530.00 | Price 7.26 | Shares 300,000
Buy 12 May 2022
Value US$492,150.00 | Price 5.79 | Shares 85,000
Buy 12 May 2022
Value US$9,021,800.93 | Price 6.41 | Shares 1,408,468
Buy 4 Mar 2022
Value US$85,400.00 | Price 8.54 | Shares 10,000
Buy 1 Mar 2022
Value US$181,000.00 | Price 9.05 | Shares 20,000
Buy 28 Feb 2022
Value US$1,998,632.74 | Price 8.66 | Shares 230,789
Buy 3 Dec 2021
Value US$1,218,870.76 | Price 14.02 | Shares 86,938
Buy 11 Nov 2021
Value US$2,995,912.86 | Price 14.76 | Shares 202,960
Buy 11 Nov 2021
Value US$204,540.00 | Price 14.61 | Shares 14,000
Buy 11 Nov 2021
Value US$788,590.00 | Price 14.74 | Shares 53,500
Sale 22 Jun 2021
Value US$2,550,000.00 | Price 25.50 | Shares 100,000
Sale 9 Jun 2021
Value US$30,600,000.00 | Price 25.50 | Shares 1,200,000
Sale 9 Jun 2021
Value US$10,240,290.00 | Price 25.50 | Shares 401,580
Sale 9 Jun 2021
Value US$134,530,032.60 | Price 24.03 | Shares 5,598,420
Sale 9 Jun 2021
Value US$25,500,000.00 | Price 25.50 | Shares 1,000,000
Sale 9 Jun 2021
Value US$25,500,000.00 | Price 25.50 | Shares 1,000,000
Sale 9 Jun 2021
Value US$134,530,032.60 | Price 24.03 | Shares 5,598,420
Sale 9 Jun 2021
Value US$25,500,000.00 | Price 25.50 | Shares 1,000,000
Buy 15 Dec 2020
Value US$60,000,000.00 | Price 20.00 | Shares 3,000,000
Buy 15 Dec 2020
Value US$340,000.00 | Price 20.00 | Shares 17,000
Buy 15 Dec 2020
Value US$120,000.00 | Price 20.00 | Shares 6,000
Buy 15 Dec 2020
Value US$5,000.00 | Price 20.00 | Shares 250
Buy 15 Dec 2020
Value US$5,000.00 | Price 20.00 | Shares 250
Buy 15 Dec 2020
Value US$100,000.00 | Price 20.00 | Shares 5,000
Buy 15 Dec 2020
Value US$400,000.00 | Price 20.00 | Shares 20,000
Buy 15 Dec 2020
Value US$1,473,300.00 | Price 20.00 | Shares 73,665
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-05-14 B Purchase
3.2
Montalbano John S.
Non-Executive Director
48,860 +29.9%
157.91
US$3,134,208 		48,860 +29.9% 157.91 US$3,134,208
2026-03-02 2026-02-27 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
3,444 -46.9%
26.42
US$2,890,389 		3,444 -46.9% 26.42 US$2,890,389
2026-02-27 2026-02-27 B Purchase
4.0
Booth Andrew

Chief Financial Officer

Officer
89,320 +36.8%
26.81
US$4,895,905 		89,320 +36.8% 26.81 US$4,895,905
2026-02-27 2026-02-26 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
177,457 +0.3%
3.27
US$580,284 		177,457 +0.3% 3.27 US$580,284
2025-11-26 2025-11-26 B Purchase
3.2
Montalbano John S.
Non-Executive Director
50,000 +29.2%
3.57
US$178,460 		50,000 +29.2% 3.57 US$178,460
2025-03-11 2025-03-11 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
343,631 +0.6%
2.16
US$742,243 		343,631 +0.6% 2.16 US$742,243
2025-03-10 2025-03-10 B Purchase
3.2
Montalbano John S.
Non-Executive Director
25,000 +17.1%
2.30
US$57,500 		25,000 +17.1% 2.30 US$57,500
2025-03-07 2025-03-06 B Purchase
3.2
Montalbano John S.
Non-Executive Director
60,000 +69.8%
2.34
US$140,568 		60,000 +69.8% 2.34 US$140,568
2024-08-29 2024-08-29 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
283,516 +0.5%
2.61
US$739,977 		283,516 +0.5% 2.61 US$739,977
2023-11-08 2023-11-08 B Purchase
3.2
Montalbano John S.
Non-Executive Director
10,000 +13.2%
4.46
US$44,600 		10,000 +13.2% 4.46 US$44,600
2023-11-08 2023-11-06 B Purchase
3.2
Montalbano John S.
Non-Executive Director
20,000 +35.7%
4.64
US$92,800 		20,000 +35.7% 4.64 US$92,800
2023-09-26 2023-09-22 B Purchase
3.1
Hayden Michael R
Non-Executive Director
20,000 +1.5%
4.91
US$98,200 		20,000 +1.5% 4.91 US$98,200
2023-09-14 2023-09-12 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
20,000 +1.0%
5.19
US$103,800 		20,000 +1.0% 5.19 US$103,800
2023-08-09 2023-08-08 B Purchase
3.1
Hayden Michael R
Non-Executive Director
30,000 +2.4%
5.90
US$177,000 		30,000 +2.4% 5.90 US$177,000
2023-05-26 2023-05-26 B Purchase
4.0
Booth Andrew

Chief Financial Officer

Officer
14,500 +10.5%
6.85
US$99,325 		14,500 +10.5% 6.85 US$99,325
2023-05-26 2023-05-26 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
153,000 +0.3%
6.52
US$997,728 		153,000 +0.3% 6.52 US$997,728
2022-12-20 2022-12-16 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
85,102 +0.2%
10.10
US$859,249 		85,102 +0.2% 10.10 US$859,249
2022-08-22 2022-08-19 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
200,000 +0.4%
11.46
US$2,292,460 		200,000 +0.4% 11.46 US$2,292,460
2022-06-15 2022-06-14 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
9,173 +0.0%
8.05
US$73,842 		9,173 +0.0% 8.05 US$73,842
2022-06-15 2022-06-13 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
54,915 +0.1%
8.03
US$441,066 		54,915 +0.1% 8.03 US$441,066
2022-06-08 2022-06-06 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
64,545 +0.1%
7.50
US$483,965 		64,545 +0.1% 7.50 US$483,965
2022-05-17 2022-05-16 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
200,000 +12.7%
6.34
US$1,267,780 		200,000 +12.7% 6.34 US$1,267,780
2022-05-17 2022-05-13 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
300,000 +0.5%
7.26
US$2,176,530 		300,000 +0.5% 7.26 US$2,176,530
2022-05-16 2022-05-12 B Purchase
4.0
Booth Andrew

Chief Financial Officer

Officer
85,000 +158.9%
5.79
US$492,150 		85,000 +158.9% 5.79 US$492,150
2022-05-16 2022-05-12 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
1,408,468 +2.6%
6.41
US$9,021,801 		1,408,468 +2.6% 6.41 US$9,021,801
2022-03-04 2022-03-04 B Purchase
3.2
Montalbano John S.
Non-Executive Director
10,000 +21.7%
8.54
US$85,400 		10,000 +21.7% 8.54 US$85,400
2022-03-03 2022-03-01 B Purchase
3.2
Montalbano John S.
Non-Executive Director
20,000 +76.9%
9.05
US$181,000 		20,000 +76.9% 9.05 US$181,000
2022-03-01 2022-02-28 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
230,789 +17.2%
8.66
US$1,998,633 		230,789 +17.2% 8.66 US$1,998,633
2021-12-07 2021-12-03 B Purchase
2.5
Lo Andrew
Non-Executive Director
86,938 +inf%
14.02
US$1,218,871 		86,938 +inf% 14.02 US$1,218,871
2021-11-15 2021-11-11 B Purchase
4.2
Thermopylae Holdings Ltd.
Large shareholder
202,960 +0.4%
14.76
US$2,995,913 		202,960 +0.4% 14.76 US$2,995,913
2021-11-15 2021-11-11 B Purchase
4.0
Booth Andrew

Chief Financial Officer

Officer
14,000 +12.0%
14.61
US$204,540 		14,000 +12.0% 14.61 US$204,540
2021-11-15 2021-11-11 B Purchase
4.0
Booth Andrew

Chief Financial Officer

Officer
53,500 +inf%
14.74
US$788,590 		53,500 +inf% 14.74 US$788,590
2021-06-22 2021-06-22 S Sale
3.1
Hayden Michael R
Non-Executive Director
100,000 -9.1%
25.50
US$2,550,000 		100,000 -9.1% 25.50 US$2,550,000
2021-06-10 2021-06-09 S Sale
4.0
Booth Andrew

Chief Financial Officer

Officer
1,200,000 -100.0%
25.50
US$30,600,000 		1,200,000 -100.0% 25.50 US$30,600,000
2021-06-10 2021-06-09 S Sale
3.3
Hansen Carl L. G.

Chief Executive Officer

Executive Director Large shareholder
401,580 -63.2%
25.50
US$10,240,290 		401,580 -63.2% 25.50 US$10,240,290
2021-06-10 2021-06-09 S Sale
3.3
Hansen Carl L. G.

Chief Executive Officer

Executive Director Large shareholder
5,598,420 -9.1%
24.03
US$134,530,033 		5,598,420 -9.1% 24.03 US$134,530,033
2021-06-10 2021-06-09 S Sale
3.3
Stimart Tryn

Chief Legal Officer

Officer
1,000,000 -100.0%
25.50
US$25,500,000 		1,000,000 -100.0% 25.50 US$25,500,000
2021-06-10 2021-06-09 S Sale
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
1,000,000 -78.5%
25.50
US$25,500,000 		1,000,000 -78.5% 25.50 US$25,500,000
2021-06-10 2021-06-09 S Sale
4.2
Thermopylae Holdings Ltd.
Large shareholder
5,598,420 -9.1%
24.03
US$134,530,033 		5,598,420 -9.1% 24.03 US$134,530,033
2021-06-10 2021-06-09 S Sale
3.3
Falconer Ester

Chief Technology Officer

Officer
1,000,000 -100.0%
25.50
US$25,500,000 		1,000,000 -100.0% 25.50 US$25,500,000
2020-12-17 2020-12-15 B Purchase
1.3
THIEL PETER
Non-Executive Director
3,000,000 +41.8%
20.00
US$60,000,000 		3,000,000 +41.8% 20.00 US$60,000,000
2020-12-17 2020-12-15 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
17,000 +38.1%
20.00
US$340,000 		17,000 +38.1% 20.00 US$340,000
2020-12-17 2020-12-15 B Purchase
3.3
Stimart Tryn

Chief Legal Officer

Officer
250 +inf%
20.00
US$5,000 		250 +inf% 20.00 US$5,000
2020-12-17 2020-12-15 B Purchase
3.2
Montalbano John S.
Non-Executive Director
5,000 +inf%
20.00
US$100,000 		5,000 +inf% 20.00 US$100,000
2020-12-17 2020-12-15 B Purchase
3.1
Hayden Michael R
Non-Executive Director
73,665 +165.2%
20.00
US$1,473,300 		73,665 +165.2% 20.00 US$1,473,300
2020-12-17 2020-12-15 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
6,000 +0.6%
20.00
US$120,000 		6,000 +0.6% 20.00 US$120,000
2020-12-17 2020-12-15 B Purchase
3.3
Stimart Tryn

Chief Legal Officer

Officer
250 +inf%
20.00
US$5,000 		250 +inf% 20.00 US$5,000
2020-12-17 2020-12-15 B Purchase
3.2
Montalbano John S.
Non-Executive Director
20,000 +inf%
20.00
US$400,000 		20,000 +inf% 20.00 US$400,000
Explore more

More insider trading research around Abcellera Biologics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America